Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
Identifieur interne : 000D49 ( Main/Exploration ); précédent : 000D48; suivant : 000D50Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
Auteurs : James. Sheffield [États-Unis] ; Joseph Jankovic [États-Unis]Source :
- Expert review of neurotherapeutics ; 2007.
English descriptors
- KwdEn :
- Antidepressive Agents, Second-Generation (administration & dosage), Botulinum Toxins (administration & dosage), Clinical Trials as Topic (trends), Dose-Response Relationship, Drug, Dystonia (drug therapy), Dystonia (etiology), Humans, Parkinson Disease (complications), Parkinson Disease (drug therapy), Practice Patterns, Physicians' (trends), Sialorrhea (drug therapy), Sialorrhea (etiology), Treatment Outcome, Tremor (drug therapy), Tremor (etiology).
- MESH :
- chemical , administration & dosage : Antidepressive Agents, Second-Generation, Botulinum Toxins.
- complications : Parkinson Disease.
- drug therapy : Dystonia, Parkinson Disease, Sialorrhea, Tremor.
- etiology : Dystonia, Sialorrhea, Tremor.
- trends : Clinical Trials as Topic, Practice Patterns, Physicians'.
- Dose-Response Relationship, Drug, Humans, Treatment Outcome.
Abstract
Botulinum toxins are an effective treatment modality for a growing number of neurologic conditions. Although there has been varied interest and success in their use, they have been studied for a variety of conditions associated with Parkinson's disease. Conditions reviewed in this paper include hand and jaw tremor, dystonia, blepharospasm and apraxia of eyelid opening, bruxism, camptocormia, freezing of gait, sialorrhea and constipation. We will make comments when applicable on our unique experience with botulinum toxin in these conditions. Other conditions associated with Parkinson's disease, which will not be reviewed here, but may benefit from botulinum toxin treatment include anterocollis (also known as dropped head syndrome), hyperhidrosis, seborrhea and overactive bladder.
DOI: 10.1586/14737175.7.6.637
PubMed: 17563247
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000160
- to stream PubMed, to step Curation: 000160
- to stream PubMed, to step Checkpoint: 000169
- to stream Ncbi, to step Merge: 000147
- to stream Ncbi, to step Curation: 000147
- to stream Ncbi, to step Checkpoint: 000147
- to stream Main, to step Merge: 000D76
- to stream Main, to step Curation: 000D49
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.</title><author><name sortKey="Sheffield, James K" sort="Sheffield, James K" uniqKey="Sheffield J" first="James" last="Sheffield">James. Sheffield</name><affiliation wicri:level="2"><nlm:affiliation>Department of Neurology, Baylor College of Medicine, Parkinson's Disease Center & Movement Disorders Clinic, 6550 Fannin, Suite 1801, Houston, TX 77030, USA. jksheffi@bcm.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Baylor College of Medicine, Parkinson's Disease Center & Movement Disorders Clinic, 6550 Fannin, Suite 1801, Houston, TX 77030</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation><country>États-Unis</country><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="doi">10.1586/14737175.7.6.637</idno><idno type="RBID">pubmed:17563247</idno><idno type="pmid">17563247</idno><idno type="wicri:Area/PubMed/Corpus">000160</idno><idno type="wicri:Area/PubMed/Curation">000160</idno><idno type="wicri:Area/PubMed/Checkpoint">000169</idno><idno type="wicri:Area/Ncbi/Merge">000147</idno><idno type="wicri:Area/Ncbi/Curation">000147</idno><idno type="wicri:Area/Ncbi/Checkpoint">000147</idno><idno type="wicri:Area/Main/Merge">000D76</idno><idno type="wicri:Area/Main/Curation">000D49</idno><idno type="wicri:Area/Main/Exploration">000D49</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.</title><author><name sortKey="Sheffield, James K" sort="Sheffield, James K" uniqKey="Sheffield J" first="James" last="Sheffield">James. Sheffield</name><affiliation wicri:level="2"><nlm:affiliation>Department of Neurology, Baylor College of Medicine, Parkinson's Disease Center & Movement Disorders Clinic, 6550 Fannin, Suite 1801, Houston, TX 77030, USA. jksheffi@bcm.edu</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Neurology, Baylor College of Medicine, Parkinson's Disease Center & Movement Disorders Clinic, 6550 Fannin, Suite 1801, Houston, TX 77030</wicri:regionArea><placeName><region type="state">Texas</region></placeName></affiliation></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation><country>États-Unis</country><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author></analytic><series><title level="j">Expert review of neurotherapeutics</title><idno type="e-ISSN">1744-8360</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antidepressive Agents, Second-Generation (administration & dosage)</term><term>Botulinum Toxins (administration & dosage)</term><term>Clinical Trials as Topic (trends)</term><term>Dose-Response Relationship, Drug</term><term>Dystonia (drug therapy)</term><term>Dystonia (etiology)</term><term>Humans</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (drug therapy)</term><term>Practice Patterns, Physicians' (trends)</term><term>Sialorrhea (drug therapy)</term><term>Sialorrhea (etiology)</term><term>Treatment Outcome</term><term>Tremor (drug therapy)</term><term>Tremor (etiology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antidepressive Agents, Second-Generation</term><term>Botulinum Toxins</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dystonia</term><term>Parkinson Disease</term><term>Sialorrhea</term><term>Tremor</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dystonia</term><term>Sialorrhea</term><term>Tremor</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Clinical Trials as Topic</term><term>Practice Patterns, Physicians'</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Dose-Response Relationship, Drug</term><term>Humans</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Botulinum toxins are an effective treatment modality for a growing number of neurologic conditions. Although there has been varied interest and success in their use, they have been studied for a variety of conditions associated with Parkinson's disease. Conditions reviewed in this paper include hand and jaw tremor, dystonia, blepharospasm and apraxia of eyelid opening, bruxism, camptocormia, freezing of gait, sialorrhea and constipation. We will make comments when applicable on our unique experience with botulinum toxin in these conditions. Other conditions associated with Parkinson's disease, which will not be reviewed here, but may benefit from botulinum toxin treatment include anterocollis (also known as dropped head syndrome), hyperhidrosis, seborrhea and overactive bladder.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region><settlement><li>Houston</li></settlement><orgName><li>Baylor College of Medicine</li></orgName></list><tree><country name="États-Unis"><region name="Texas"><name sortKey="Sheffield, James K" sort="Sheffield, James K" uniqKey="Sheffield J" first="James" last="Sheffield">James. Sheffield</name></region><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D49 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D49 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= JankovicV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:17563247
|texte= Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:17563247" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a JankovicV1
| This area was generated with Dilib version V0.6.19. |  |